Generex Webcast Regarding Oralin Launch In Ecuador
Filed in archive Corporate and Industrial News on September 28, 2005
In preparation for the pending commercial launch of Oralin in ecuador,
Generex Biotechnology Corporation hosted a press conference yesterday afternoon at its Toronto offices to provide the European press with an overview of the Company and its proprietary buccal drug delivery platform technologies, particularly the status of the clinical and regulatory global development program for Oralin, its proprietary oral insulin buccal spray for the treatment of both type 1 and type 2 diabetes.
A webcast of the press conference is available here. To dial in and listen to the webcast please call 1-706-643-7496 .
Tags: diabetes insulin biotech webcast oralin generex+webcast launch+ecuador oralin+launch
Vote for Generex Webcast Regarding Oralin Launch In Ecuador:
|
Rating: 7.60 out of 10 vote(s) cast.
|
| RSS |  |
 | |
| Yahoo! |
|
| Addthis |
|
| Bloglines |
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells